{"nct_id":"NCT02706847","title":"A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs","status":"COMPLETED","status_verified_date":"2023-01","start_date":"2016-03-15","start_date_type":"ACTUAL","primary_completion_date":"2017-04-03","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}